Sponsored by Ultragenyx Pharmaceutical Inc.
| Variant ID | 917 |
|---|---|
| Genomic Coordinate (GRCh38) | g.22247849A>T |
| Variant | c.2148-2A>T |
| Variant Start Position | 2148 |
| Location | Intron 21 |
| Amino Acid Change | p.? |
| ACMG Call | - |
| ACMG Call Last Revised Date | 4/28/2021 |
| Predicted ACMG Call | Pathogenic | Effect Type | Splice acceptor |
| Variant Type | Splicing |
| PMID | 16636593, 34806794 |
| Article Count | 2 |
| Times Observed | < 3 |
| Clinical Phenotype | - |
| ACMG Categories | pvs1, pm2 |
| ACMG Explanations | pvs1: This is a loss of function variant. pm2: chrX:22265966 ref:A alt:T was not found in gnomAD exomes or genomes. |
| Variant in Clinvar | No |
| ClinVar Classification | - |
| Categories In Literature | - |
| No Contrary Evidence Found | TRUE |
| ExAC Allele Frequency | 0 |
| Thousand Genomes Allel Frequency | 0 |
| Ontology Relations | - |
| hg19 Mapping Failed | FALSE |
| Literature Alleles | X-22265966-A-T |
| GnomAD Alleles | - |
| DBNSFP Alleles | X-22265966-A-T |
| Other Alleles | - |
| Note | nan |
| Warnings | - |